Deals by sector
Track the healthcare deals published in the Exit Mode archive, with sourced facts, narrative context, and founder-relevant patterns.
Healthcare deals tell founders where buyers are concentrating, how fast consolidation is moving, and what strategic acquirers or PE firms appear willing to back. This archive view is built to make that signal easier to track without mixing sourced facts and editorial opinion into the same layer.
VitalHub UK Limited has agreed to acquire Induction Healthcare Group PLC in a strategic acquisition within the healthcare sector. The transaction involves a cash conside…
Thermo Fisher Scientific has agreed to acquire the Purification and Filtration business of Solventum in a strategic acquisition. The transaction involves the transfer of…
Solvonis Therapeutics PLC has agreed to acquire Awakn, a biopharmaceutical company based in Canada, in a strategic acquisition. The transaction was announced on 28 May 2…
AEGROS BIDCO LIMITED has agreed to acquire Alliance Pharma PLC in a strategic acquisition within the pharmaceutical sector. The transaction was announced on 12 May 2025…
Hellman & Friedman and CVC have agreed to acquire Mehiläinen, a Finnish healthcare provider, in a private equity acquisition announced on 11 May 2025. The transaction in…
Catheter Precision, Inc. and Cardionomic, Inc. entered the Exit Mode archive.
MADISON DEARBORN PARTNERS and THOMA BRAVO have agreed to acquire NEXTGEN HEALTHCARE in a private equity acquisition. The transaction was announced on 4 May 2025. The tar…
Merck KGaA, Darmstadt, Germany and SpringWorks Therapeutics, Inc. entered the Exit Mode archive.
Coeptis Therapeutics Holdings, Inc. and Z Squared Inc. entered the Exit Mode archive.
IK PARTNERS and SAGARD have agreed to acquire Sterimed in a transaction announced on 7 April 2025. The deal involves a diverse portfolio of activities spanning medical e…
Johnson & Johnson and Intra-Cellular Therapies, Inc. entered the Exit Mode archive.
PAI Partners has agreed to acquire Motel One in a private equity acquisition. The deal was announced on 23 March 2025. The transaction involves the purchase of the hotel…
Paratek Pharmaceuticals, Inc. and OptiNose, Inc. entered the Exit Mode archive.
PURE HEALTH HOLDING has agreed to acquire HELLENIC HEALTHCARE in a transaction announced on 23 February 2025. The deal involves a company operating within the NaceV2Sect…
ALCENTRA has agreed to acquire PEOPLE & BABY in a strategic acquisition announced on 12 February 2025. The target operates within the NaceV2Sector_R_88.91 classification…
Zimmer, Inc. and Paragon 28, Inc. entered the Exit Mode archive.
ROQUETTE has agreed to acquire the IFF Pharma Solutions business in a strategic acquisition. The transaction was announced on 13 January 2025 and currently remains subje…
Transcarent, Inc. and Accolade, Inc. entered the Exit Mode archive.
CD&R has agreed to acquire OPELLA in a transaction announced on 7 January 2025. The deal involves the private equity firm purchasing the company, which operates within t…
GENERAL ATLANTIC and PSG have agreed to acquire Hostaway in a private equity acquisition. The transaction was announced on 5 January 2025. The deal value remains undiscl…
K2 VBI Equity Trust, LLC and VBI Vaccines Inc. entered the Exit Mode archive.
Patient Square Capital and Patterson Companies, Inc. entered the Exit Mode archive.
Space Finco, Inc. and Avid Bioservices, Inc. entered the Exit Mode archive.
NOVO HOLDINGS and CATALENT entered the Exit Mode archive.
KKR / BAUPOST and MARRIOTT ASSETS entered the Exit Mode archive.
MIDEUROPA PARTNERS and FAMAR entered the Exit Mode archive.
PLATINUM EQUITY GROUP and SUNRISE MEDICAL entered the Exit Mode archive.
Boston Scientific Corporation and Silk Road Medical, Inc. entered the Exit Mode archive.
KARL STORZ Endoscopy-America, Inc. and Asensus Surgical, Inc. entered the Exit Mode archive.
Roche Diagnostics Limited and LumiraDx Group Limited (in administration) and LumiraDx International Limited (in administration) entered the Exit Mode archive.
Exit Mode Insider
Ten curated deal briefs a week, plus founder commentary on the patterns worth paying attention to. £12/month, cancel anytime.
Keep browsing
